Table of Content


Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Business trends
Chapter 3 US Clinical Nutrition Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing metabolic disorders and other chronic diseases
3.3.1.2 High junk food consumption leading to malnourishment
3.3.1.3 Rising geriatric population worldwide
3.3.1.4 Increasing incidence of pre-mature birth & birth rate
3.3.1.5 Increasing adoption of home healthcare
3.3.2 Industry pitfalls & challenges
3.3.2.1 Stringent government regulations
3.4 Growth potential analysis
3.4.1 By type
3.4.2 By product
3.4.3 By formulation
3.4.4 By consumer
3.4.5 By application
3.4.6 By distribution channel
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.7 Porter’s analysis
3.8 Competitive landscape, 2021
3.8.1 Competitive matrix analysis, 2021
3.9 PESTEL analysis
Chapter 4 US Clinical Nutrition Market, By Product
4.1 Key segment trends
4.2 Infant nutrition
4.2.1 Market size, 2017 - 2030 (USD Million)
4.2.2 Milk based
4.2.2.1 Market size, 2017 - 2030 (USD Million)
4.2.3 Soy based
4.2.3.1 Market size, 2017 - 2030 (USD Million)
4.2.4 Organic formulas
4.2.4.1 Market size, 2017 - 2030 (USD Million)
4.2.5 Others
4.2.5.1 Market size, 2017 - 2030 (USD Million)
4.3 Enteral nutrition
4.3.1 Market size, 2017 - 2030 (USD Million)
4.3.2 Standard composition
4.3.2.1 Market size, 2017 - 2030 (USD Million)
4.3.3 Disease specific composition
4.3.3.1 Market size, 2017 - 2030 (USD Million)
4.4 Parenteral nutrition
4.4.1 Market size, 2017 - 2030 (USD Million)
4.4.2 Amino acids
4.4.2.1 Market size, 2017 - 2030 (USD Million)
4.4.3 Fats
4.4.3.1 Market size, 2017 - 2030 (USD Million)
4.4.4 Carbohydrates
4.4.4.1 Market size, 2017 - 2030 (USD Million)
4.4.5 Others
4.4.5.1 Market size, 2017 - 2030 (USD Million)
Chapter 5 US Clinical Nutrition Market, By Consumer
5.1 Key segment trends
5.2 Pediatric
5.2.1 Market size, 2017 - 2030 (USD Million)
5.3 Adult
5.3.1 Market size, 2017 - 2030 (USD Million)
Chapter 6 US Clinical Nutrition Market, By Application
6.1 Key segment trends
6.2 Cancer
6.2.1 Market size, 2017 - 2030 (USD Million)
6.3 Metabolic disorders
6.3.1 Market size, 2017 - 2030 (USD Million)
6.4 Neurological diseases
6.4.1 Market size, 2017 - 2030 (USD Million)
6.5 Gastrointestinal disorders
6.5.1 Market size, 2017 - 2030 (USD Million)
6.6 Others
6.6.1 Market size, 2017 - 2030 (USD Million)
Chapter 7 US Clinical Nutrition Market, By Distribution Channel
7.1 Key segment trends
7.2 Retail stores
7.2.1 Market size, 2017 - 2030 (USD Million)
7.3 Pharmacies & drug stores
7.3.1 Market size, 2017 - 2030 (USD Million)
7.4 Online channels
7.4.1 Market size, 2017 - 2030 (USD Million)
7.5 Others
7.5.1 Market size, 2017 - 2030 (USD Million)
Chapter 8 Company Profiles
8.1 Competitive dashboard, 2021
8.2 Abbott Laboratories (Abbott Nutrition)
8.2.1 Business overview
8.2.2 Financial data
8.2.3 Product landscape
8.2.4 Strategic outlook
8.2.5 SWOT analysis
8.3 B Braun Melsungen AG
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Product landscape
8.3.4 Strategic outlook
8.3.5 SWOT analysis
8.4 Baxter International Inc.
8.4.1 Business overview
8.4.2 Financial data
8.4.3 Product landscape
8.4.4 Strategic outlook
8.4.5 SWOT analysis
8.5 Fresenius Kabi
8.5.1 Business overview
8.5.2 Financial data
8.5.3 Product landscape
8.5.4 Strategic outlook
8.5.5 SWOT analysis
8.6 Mead Johnson (Reckitt Benckiser)
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Product landscape
8.6.4 Strategic outlook
8.6.5 SWOT analysis
8.7 Nestle Health Science
8.7.1 Business overview
8.7.2 Financial data
8.7.3 Product landscape
8.7.4 Strategic outlook
8.7.5 SWOT analysis
8.8 Perrigo
8.8.1 Business overview
8.8.2 Financial data
8.8.3 Product landscape
8.8.4 Strategic outlook
8.8.5 SWOT analysis
8.9 Pfizer, Inc.
8.9.1 Business overview
8.9.2 Financial data
8.9.3 Product landscape
8.9.4 Strategic outlook
8.9.5 SWOT analysis
8.10 Danone
8.10.1 Business overview
8.10.2 Financial data
8.10.3 Product landscape
8.10.4 Strategic outlook
8.10.5 SWOT analysis
8.11 Hero Nutritionals Inc.
8.11.1 Business overview
8.11.2 Financial data
8.11.3 Product landscape
8.11.4 Strategic outlook
8.11.5 SWOT analysis



List of Tables

Data Tables
TABLE 1 U.S. clinical nutrition market, 2017 - 2021 (USD Million)
TABLE 2 U.S. clinical nutrition market, 2022 - 2030 (USD Million)
TABLE 3 Industry impact forces
TABLE 4 Infant nutrition market, 2017 - 2021, (USD Million)
TABLE 5 Infant nutrition market, 2022 - 2030, (USD Million)
TABLE 6 Milk based market, 2017 - 2021, (USD Million)
TABLE 7 Milk based market, 2022 - 2030, (USD Million)
TABLE 8 Soy based market, 2017 - 2021, (USD Million)
TABLE 9 Soy based market, 2022 - 2030, (USD Million)
TABLE 10 Organic formulas market, 2017 - 2021, (USD Million)
TABLE 11 Organic formulas market, 2022 - 2030, (USD Million)
TABLE 12 Others market, 2017 - 2021, (USD Million)
TABLE 13 Others market, 2022 - 2030, (USD Million)
TABLE 14 Enteral nutrition market, 2017 - 2021, (USD Million)
TABLE 15 Enteral nutrition market, 2022 - 2030, (USD Million)
TABLE 16 Standard composition market, 2017 - 2021, (USD Million)
TABLE 17 Standard composition market, 2022 - 2030, (USD Million)
TABLE 18 Disease specific composition market, 2017 - 2021, (USD Million)
TABLE 19 Disease specific composition market, 2022 - 2030, (USD Million)
TABLE 20 Parenteral nutrition market, 2017 - 2021, (USD Million)
TABLE 21 Parenteral nutrition market, 2022 - 2030, (USD Million)
TABLE 22 Amino acids market, 2017 - 2021, (USD Million)
TABLE 23 Amino acids market, 2022 - 2030, (USD Million)
TABLE 24 Fats market, 2017 - 2021, (USD Million)
TABLE 25 Fats market, 2022 - 2030, (USD Million)
TABLE 26 Carbohydrates market, 2017 - 2021, (USD Million)
TABLE 27 Carbohydrates market, 2022 - 2030, (USD Million)
TABLE 28 Others market, 2017 - 2021, (USD Million)
TABLE 29 Others market, 2022 - 2030, (USD Million)
TABLE 30 Pediatric market, 2017 - 2021, (USD Million)
TABLE 31 Pediatric market, by region, 2022 - 2030, (USD Million)
TABLE 32 Adult market, 2017 - 2021, (USD Million)
TABLE 33 Adult market, 2022 - 2030, (USD Million)
TABLE 34 Cancer market, 2017-2021, (USD Million)
TABLE 35 Cancer market, 2022-2030, (USD Million)
TABLE 36 Metabolic disorders market, 2017-2021, (USD Million)
TABLE 37 Metabolic disorders market, 2022-2030, (USD Million)
TABLE 38 Neurological diseases market, 2017-2021, (USD Million)
TABLE 39 Neurological diseases market, 2022-2030, (USD Million)
TABLE 40 Gastrointestinal disorders market, 2017-2021, (USD Million)
TABLE 41 Gastrointestinal disorders market, 2022-2030, (USD Million)
TABLE 42 Others market, 2017-2021, (USD Million)
TABLE 43 Others market, 2022-2030, (USD Million)
TABLE 44 Retail stores market, 2017-2021, (USD Million)
TABLE 45 Retail stores market, 2022-2030, (USD Million)
TABLE 46 Pharmacies and drug stores market, 2017-2021, (USD Million)
TABLE 47 Pharmacies and drug stores market, 2022-2030, (USD Million)
TABLE 48 Online channels market, 2017-2021, (USD Million)
TABLE 49 Online channels market, 2022-2030, (USD Million)
TABLE 50 Others market, 2017-2021, (USD Million)
TABLE 51 Others market, 2022-2030, (USD Million)

Charts & Figures
FIG. 1 Top-down approach
FIG. 2 Breakdown of primary participants
FIG. 3 Industry segmentation
FIG. 4 Industry landscape, 2017 - 2030 (USD Million)
FIG. 5 Growth potential analysis, by product
FIG. 6 Growth potential analysis, by consumer
FIG. 7 Growth potential analysis, by application
FIG. 8 Growth potential analysis, by distribution channel
FIG. 9 Porter’s analysis
FIG. 10 Company matrix analysis, 2021
FIG. 11 PESTEL analysis
FIG. 12 Key segment trends, by product
FIG. 13 Key segment trends, by consumer
FIG. 14 Key segmental trends, by application
FIG. 15 Key segmental trends, by distribution channel
FIG. 16 Strategy dashboard, 2021